Aperio Announces Strategic Collaboration with Dell

AperioAperio, the leading provider of digital pathology systems, announced a strategic collaboration with Dell to create the world's first scalable, secure medical cloud network for Pathology.

Through its secure cloud-based Unified Clinical Archive solution, Dell manages nearly 5 billion medical images and studies for healthcare organizations. And now, Dell will host the existing suite of Aperio's industry-leading solutions for digital pathology. Fortified by Dell's standards-based technology and storage capabilities, Aperio's ePathology Network™ solution will provide secure, compliant, worldwide access to pathology consultations via the cloud.

"Our goal is to address the regional and global imbalances of pathology expertise available for patient care by enabling access to pathologists for all types of consultations, regardless of location. With Dell's cloud-based archiving platform, we can make our ePathology Solutions™ more widely available." said David Schlotterbeck, CEO of Aperio.

"This state-of-the-art ePathology Network technology from Aperio will revolutionize the practice of secondary consultations," states Dr. Jonathan Epstein, Director of Surgical Pathology at Johns Hopkins. "We fully expect that the time to return an opinion on these cases will be significantly reduced - from multiple days to as a few as a couple of hours in critical cases. This will have a significant positive impact on patient care."

Dell and Aperio are also collaborating to develop the world's leading repository of characterized digital slide images and cases, which will include the Juan Rosai Collection of Surgical Pathology Seminars. This furthers another mission of Aperio to make quality educational and reference materials more readily available to all pathologists around the world. The eSlide Repository™ will be a fulcrum for the healthcare and life sciences industries' focus on personalized medicine and enhanced precision and predictability.

"Dell is excited to work with Aperio to facilitate the archiving and sharing of whole slide pathology images via the cloud," said James Coffin, Ph.D., vice president and general manager of Dell Healthcare and Life Sciences. "This is a prime example of how on-premise and cloud-based solutions with application-neutral data management capabilities can break down traditional information silos and allow healthcare organizations to securely manage, store and share data to advance patient care."

About Aperio
For over a decade, Aperio has advanced the technology that enables glass slides to be digitized and securely shared with others. Aperio products are transforming the practice of pathology in hospitals, reference labs and pharmaceutical and research institutions around the world. From the moment glass slides are elevated to eSlides, Aperio ePathology Solutions equip pathologists with the power to evaluate, engage and excel like never before. The NETWORK enables remote, simultaneous, real-time viewing and easy distribution for consults and collaboration. PRECISION tools empower pathologists with advanced analytic capabilities. An interoperable, scalable and secure web-based software platform facilitates integration with existing systems. With Aperio ePathology Solutions, organizations can optimize their pathology operations for transparency, consistency and efficiency to support patient care, personalized medicine and research. For clearance updates, specific product indications, and more information please visit www.aperio.com.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

AI-Based Chatbot Created for Bioimage An…

Scientists from Universidad Carlos III de Madrid (UC3M), together with a research team from Ericsson and the KTH Royal Institute of Technology in Sweden, have developed an artificial intelligence-based software...